An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis (Q57417002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

title

An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

glucocorticoid-induced osteoporosis

20 February 2020

main subject

osteoporosis

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

Richard Eastell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

Lorenz C Hofbauer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

Olga Lesnyak

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

Nicola Napoli

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

Jan J. Štěpán

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

author name string

S Lekamwasam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

J D Adachi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

D Agnusdei

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

J Bilezikian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

S Boonen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

F Borgström

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

A Diez Perez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

J A Kanis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

B L Langdahl

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

R Lorenc

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

E McCloskey

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

O D Messina

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

B Obermayer-Pietsch

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

S H Ralston

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

P N Sambrook

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

S Silverman

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

M Sosa

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

G Suppan

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

D A Wahl

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

J E Compston

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

Joint IOF–ECTS GIO Guidelines Working Group

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

21 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Archives of Osteoporosis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

issue

1-2

0 references

page(s)

25-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Review and evaluation of the Dutch guidelines for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11657-012-0070-7

10.1007/S11657-012-0070-7

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225278 AND SRC:MED&resulttype=core&format=json

20 February 2020

1 reference